Citi Reiterates Neutral Rating on Arrowhead Pharma (ARWR)
Go back to Citi Reiterates Neutral Rating on Arrowhead Pharma (ARWR)| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 70.96 -2.9 (3.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.86 | 52 Week High | $8.22 | |||
| Open | $75.00 | 52 Week Low | $3.07 | |||
| Day High | $76.20 | P/E | N/A | |||
| Day Low | $70.96 | EPS | $-1.30 | |||
| Volume | 467,542 | |||||
